Related Experiment Video
Updated: Mar 22, 2026

10:03
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
17.7K
Reverse Genetics Approaches to Control Arenavirus
Luis Martínez-Sobrido1, Benson Yee Hin Cheng2, Juan Carlos de la Torre3
1Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY, 14642, USA. luis_martinez@urmc.rochester.edu.
Methods in Molecular Biology (Clifton, N.J.)
|April 15, 2016
Summary
Reverse genetics enables the study and development of arenavirus vaccines and therapies. These advanced techniques allow for creating novel vaccines and drug targets for hemorrhagic fever viruses.
Area of Science:
- Virology
- Molecular Biology
- Vaccinology
Background:
- Arenaviruses cause severe hemorrhagic fever, posing a significant public health threat.
- Current treatments, including ribavirin, are limited and partially effective.
- No licensed vaccines are available for human arenavirus infections.
Purpose of the Study:
- To review the application of arenavirus reverse genetics.
- To highlight the development of vaccines and vaccine vectors.
- To discuss novel antiviral drug discovery strategies.
Main Methods:
- Utilizing cell-based minigenome systems to study viral replication and transcription.
- Generating infectious arenaviruses from cDNA for pathogenesis studies and drug screening.
- Developing tri-segmented and single-cycle reporter-expressing arenaviruses.
Main Results:
- Reverse genetics facilitates the identification of drug targets and the creation of live-attenuated vaccines.
- Novel vaccine vectors and improved detection methods have been developed.
- Safer experimental models for studying highly pathogenic arenaviruses are now available.
Conclusions:
- Arenavirus reverse genetics is a powerful tool for advancing vaccine and therapeutic development.
- These techniques are crucial for combating arenavirus-induced diseases.
- Future research directions include enhanced vaccine strategies and drug discovery.

